John Overdeck’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

John Overdeck’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$237M	Buy	1,497,968 +1,156,799	+339%	+$156M	0.17%	123
2026 Q1	$43.6M	Sell	341,169 -1,421,431	-81%	-$177M	0.04%	551
2025 Q4	$215M	Buy	1,762,600 +1,754,300	+21,136%	+$201M	0.3%	60
2025 Q3	$832K	Buy	+8,300	New	+$748K	﹤0.01%	2704
2024 Q3	–	Sell	-321,400	Closed	-$29.8M	–	3361
2024 Q2	$29.8M	Buy	321,400 +222,600	+225%	+$20M	0.07%	341
2024 Q1	$9.38M	Sell	98,800 -168,800	-63%	-$15.7M	0.02%	678
2023 Q4	$23.9M	Buy	+267,600	New	+$19.9M	0.05%	376
2023 Q2	–	Sell	-733,839	Closed	-$55.9M	–	3297
2023 Q1	$55.9M	Sell	733,839 -56,831	-7%	-$4.72M	0.16%	153
2022 Q4	$65.6M	Buy	790,670 +127,270	+19%	+$10.3M	0.21%	121
2022 Q3	$52.6M	Buy	+663,400	New	+$55.9M	0.18%	143
2022 Q2	–	Sell	-371,500	Closed	-$33.4M	–	2983
2022 Q1	$33.4M	Buy	371,500 +246,142	+196%	+$22.7M	0.1%	258
2021 Q4	$14M	Buy	125,358 +40,962	+49%	+$4.94M	0.03%	624
2021 Q3	$10.6M	Sell	84,396 -88,804	-51%	-$11.4M	0.02%	751
2021 Q2	$23.5M	Sell	173,200 -225,096	-57%	-$29.6M	0.05%	438
2021 Q1	$54M	Buy	398,296 +48,300	+14%	+$7.23M	0.14%	160
2020 Q4	$49.3M	Buy	349,996 +286,196	+449%	+$36.7M	0.14%	162
2020 Q3	$7.11M	Buy	+63,800	New	+$7.15M	0.03%	637
2020 Q2	–	Sell	-40,770	Closed	-$4.02M	–	3588
2020 Q1	$3.16M	Sell	40,770 -926,635	-96%	-$82.1M	0.03%	725
2019 Q4	$92M	Buy	967,405 +278,356	+40%	+$24.1M	0.28%	68
2019 Q3	$52.5M	Buy	689,049 +396,141	+135%	+$32.9M	0.18%	144
2019 Q2	$25.7M	Buy	292,908 +285,168	+3,684%	+$24.3M	0.09%	304
2019 Q1	$701K	Sell	7,740 -23,841	-75%	-$2.03M	﹤0.01%	2042
2018 Q4	$2.27M	Buy	31,581 +24,234	+330%	+$1.95M	0.01%	1180
2018 Q3	$704K	Buy	+7,347	New	+$712K	﹤0.01%	2230

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

John Overdeck's XBI Position: Q2 2026 in Review

John Overdeck increased its State Street SPDR S&P Biotech ETF (XBI) stake by 339% in Q2 2026, buying an estimated $156M and bringing the position to 1,497,968 shares worth $237M. The position accounts for 0.17% of the portfolio, ranked #123.

John Overdeck first reported a position in XBI in Q3 2018 and has held it in 24 quarters since. 931 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

John Overdeck held 1,497,968 shares of State Street SPDR S&P Biotech ETF worth $237M as of Q2 2026.
John Overdeck bought 1,156,799 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $156M.
State Street SPDR S&P Biotech ETF made up 0.17% of John Overdeck's portfolio in Q2 2026, its #123 holding.
John Overdeck first reported a position in State Street SPDR S&P Biotech ETF in Q3 2018 and has held it in 24 quarters since.
931 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.